StockWatch
·
Pharmaceuticals
Business Update5 May 2026, 03:26 pm

Granules India FY26 Earnings Call Transcript

AI Summary

Granules India Ltd. has released the transcript of its Q4 and financial year ended March 31, 2026, earnings conference call. The call, hosted by MUFG, discussed the company's financial and operational performance, strategic progress, including the GPI facility's performance and the acquisition of Senn. The company highlighted its shift towards more complex products and its growth in the U.S. generic market.

Key Highlights

  • GPI Virginia facility reached targeted operating potential in FY26.
  • GPI moved to 27th position in U.S. generics by sales value.
  • Senn acquisition turned EBITDA positive within three months.
  • Company is shifting towards complex and differentiated products.
  • Q4 reflects operational stability across API and finished dosage businesses.